Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Giannouli CC et al. Visualizing S1P-directed cellular egress by intravital imaging. 2014 Biochim. Biophys. Acta pmid:24090699
Zhang Y et al. Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression. 2014 J. Clin. Invest. pmid:24837436
Takeo T et al. Investigations of motility and fertilization potential in thawed cryopreserved mouse sperm from cold-stored epididymides. 2014 Cryobiology pmid:24201107
Xu H et al. Sphingosine-1-phosphate receptor agonist, FTY720, restores coronary flow reserve in diabetic rats. 2014 Circ. J. pmid:25319164
Fukui H et al. S1P-Yap1 signaling regulates endoderm formation required for cardiac precursor cell migration in zebrafish. 2014 Dev. Cell pmid:25313964
Adamson RH et al. Albumin modulates S1P delivery from red blood cells in perfused microvessels: mechanism of the protein effect. 2014 Am. J. Physiol. Heart Circ. Physiol. pmid:24531813
Rosen H et al. The organization of the sphingosine 1-phosphate signaling system. 2014 Curr. Top. Microbiol. Immunol. pmid:24728591
Hanson MA and Peach R Structural biology of the S1P1 receptor. 2014 Curr. Top. Microbiol. Immunol. pmid:24728592
Ishitsuka A et al. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression. 2014 Int. J. Mol. Med. pmid:25109763
Xiong H et al. SphK1 confers resistance to apoptosis in gastric cancer cells by downregulating Bim via stimulating Akt/FoxO3a signaling. 2014 Oncol. Rep. pmid:25109605
Zhao X et al. Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection. 2014 J. Mol. Cell. Cardiol. pmid:25106095
Xiong Y and Hla T S1P control of endothelial integrity. 2014 Curr. Top. Microbiol. Immunol. pmid:24728594
Mendelson K et al. Sphingosine 1-phosphate signalling. 2014 Development pmid:24346695
Tarbell JM et al. Mechanosensing at the vascular interface. 2014 Annu Rev Biomed Eng pmid:24905872
Potì F et al. Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P). 2014 Cardiovasc. Res. pmid:24891400
Chawla S et al. Exogenous sphingosine-1-phosphate boosts acclimatization in rats exposed to acute hypobaric hypoxia: assessment of haematological and metabolic effects. 2014 PLoS ONE pmid:24887065
Takabe K and Spiegel S Export of sphingosine-1-phosphate and cancer progression. 2014 J. Lipid Res. pmid:24474820
Ishizawa S et al. Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor. 2014 Clin. Exp. Nephrol. pmid:24463961
Couttas TA et al. Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis. 2014 Acta Neuropathol Commun pmid:24456642
Abu El-Asrar AM et al. Expression of bioactive lysophospholipids and processing enzymes in the vitreous from patients with proliferative diabetic retinopathy. 2014 Lipids Health Dis pmid:25496321
Speak AO et al. Altered distribution and function of natural killer cells in murine and human Niemann-Pick disease type C1. 2014 Blood pmid:24235134
Nagahashi M et al. Sphingosine-1-phosphate in chronic intestinal inflammation and cancer. 2014 Adv Biol Regul pmid:24210073
Lee H et al. 4-Deoxypyridoxine improves the viability of isolated pancreatic islets ex vivo. 2013 May-Jun Islets pmid:23756681
Egom EE et al. Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy. 2013 May-Jun Crit Rev Clin Lab Sci pmid:23885725
Ratajczak MZ et al. An emerging link in stem cell mobilization between activation of the complement cascade and the chemotactic gradient of sphingosine-1-phosphate. 2013 Jul-Aug Prostaglandins Other Lipid Mediat. pmid:22981511
Morozov VI et al. Sphingosine-1-phosphate: distribution, metabolism and role in the regulation of cellular functions. 2013 Jan-Feb Ukr Biokhim Zh (1999) pmid:23534286
Abuhusain HJ et al. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis. 2013 J. Biol. Chem. pmid:24265321
Bolli MH et al. Novel S1P1 receptor agonists--part 1: From pyrazoles to thiophenes. 2013 J. Med. Chem. pmid:24266709
Das A et al. The promotion of mandibular defect healing by the targeting of S1P receptors and the recruitment of alternatively activated macrophages. 2013 Biomaterials pmid:24064148
Donati C et al. New insights into the role of sphingosine 1-phosphate and lysophosphatidic acid in the regulation of skeletal muscle cell biology. 2013 Biochim. Biophys. Acta pmid:22877992
Taub DD et al. Distinct energy requirements for human memory CD4 T-cell homeostatic functions. 2013 FASEB J. pmid:22972918
Xiang SY et al. Lysophospholipid receptor activation of RhoA and lipid signaling pathways. 2013 Biochim. Biophys. Acta pmid:22986288
Ota K et al. TGF-β induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts. 2013 Endocrinology pmid:23861379
Harijith A et al. Sphingosine kinase 1 deficiency confers protection against hyperoxia-induced bronchopulmonary dysplasia in a murine model: role of S1P signaling and Nox proteins. 2013 Am. J. Pathol. pmid:23933064
Cortez-Retamozo V et al. Angiotensin II drives the production of tumor-promoting macrophages. 2013 Immunity pmid:23333075
Ono Y et al. Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration. 2013 Lipids Health Dis pmid:23418753
Bot M et al. Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice. 2013 PLoS ONE pmid:23700419
Saba JD and de la Garza-Rodea AS S1P lyase in skeletal muscle regeneration and satellite cell activation: exposing the hidden lyase. 2013 Biochim. Biophys. Acta pmid:22750505
García-Bernal D et al. Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function. 2013 J. Pathol. pmid:22711564
Takuwa Y et al. Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases. 2013 Biochim. Biophys. Acta pmid:22735357
Olivera A et al. Shaping the landscape: metabolic regulation of S1P gradients. 2013 Biochim. Biophys. Acta pmid:22735358
Karliner JS Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress. 2013 Biochim. Biophys. Acta pmid:22735359
Watson DG et al. The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells. 2013 Cell. Signal. pmid:23314175
Ohkawa R et al. [Sphingolipids, possible biomarkers for atherosclerotic disorders]. 2013 Rinsho Byori pmid:24369591
Yu H et al. Insulin protects apoptotic cardiomyocytes from hypoxia/reoxygenation injury through the sphingosine kinase/sphingosine 1-phosphate axis. 2013 PLoS ONE pmid:24349009
Walls SM et al. Identification of sphingolipid metabolites that induce obesity via misregulation of appetite, caloric intake and fat storage in Drosophila. 2013 PLoS Genet. pmid:24339790
Polzin A et al. Aspirin inhibits release of platelet-derived sphingosine-1-phosphate in acute myocardial infarction. 2013 Int. J. Cardiol. pmid:24169533
Kunkel GT et al. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. 2013 Nat Rev Drug Discov pmid:23954895
Gorshkova IA et al. Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest. 2013 Life Sci. pmid:23892195
Camacho L et al. Acid ceramidase as a therapeutic target in metastatic prostate cancer. 2013 J. Lipid Res. pmid:23423838
Kawahara S et al. Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells. 2013 Anticancer Drugs pmid:23426175
Yang L et al. Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis. 2013 J. Hepatol. pmid:23466305
Reichardt P et al. A role for LFA-1 in delaying T-lymphocyte egress from lymph nodes. 2013 EMBO J. pmid:23443048
Natarajan V et al. Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury. 2013 Am. J. Respir. Cell Mol. Biol. pmid:23449739
Kusch A et al. Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury. 2013 Acta Physiol (Oxf) pmid:23432924
Loetscher E et al. Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors. 2013 Biochem. Biophys. Res. Commun. pmid:23499842
Moriue T et al. Sphingosine 1-phosphate attenuates peroxide-induced apoptosis in HaCaT cells cultured in vitro. 2013 Clin. Exp. Dermatol. pmid:23837937
Adada M et al. Sphingosine-1-phosphate receptor 2. 2013 FEBS J. pmid:23879641
Gao X et al. Aberrant sphingolipid metabolism in the human fallopian tube with ectopic pregnancy. 2013 Lipids pmid:23881382
Kendig DM et al. Sphingosine-1-phosphate induced contraction of bladder smooth muscle. 2013 Eur. J. Pharmacol. pmid:24120660
Karimian G et al. Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis. 2013 Biochim. Biophys. Acta pmid:23816565
Liu Y et al. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors. 2013 J. Pathol. pmid:23839903
Usatyuk PV et al. Coronin 1B regulates S1P-induced human lung endothelial cell chemotaxis: role of PLD2, protein kinase C and Rac1 signal transduction. 2013 PLoS ONE pmid:23667561
Starzyńska T et al. An intensified systemic trafficking of bone marrow-derived stem/progenitor cells in patients with pancreatic cancer. 2013 J. Cell. Mol. Med. pmid:23672538
Osawa Y et al. Liver acid sphingomyelinase inhibits growth of metastatic colon cancer. 2013 J. Clin. Invest. pmid:23298833
Xu Y et al. Low sphingosine-1-phosphate impairs lung dendritic cells in cystic fibrosis. 2013 Am. J. Respir. Cell Mol. Biol. pmid:23239501
Evindar G et al. Exploring amino acids derivatives as potent, selective, and direct agonists of sphingosine-1-phosphate receptor subtype-1. 2013 Bioorg. Med. Chem. Lett. pmid:23245510
Billich A et al. Cellular assay for the characterization of sphingosine-1-phosphate lyase inhibitors. 2013 Anal. Biochem. pmid:23246729
Karapetyan AV et al. Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction. 2013 Stem Cells Dev. pmid:23282236
Kleinjan A et al. Topical treatment targeting sphingosine-1-phosphate and sphingosine lyase abrogates experimental allergic rhinitis in a murine model. 2013 Allergy pmid:23253209
Kager LM et al. Endogenous protein C has a protective role during Gram-negative pneumosepsis (melioidosis). 2013 J. Thromb. Haemost. pmid:23216621
Liang J et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. 2013 Cancer Cell pmid:23273921
Jiang LI et al. Regions on adenylyl cyclase VII required for selective regulation by the G13 pathway. 2013 Mol. Pharmacol. pmid:23229509
Park K et al. A novel role of a lipid species, sphingosine-1-phosphate, in epithelial innate immunity. 2013 Mol. Cell. Biol. pmid:23230267
Camprubí-Robles M et al. Sphingosine-1-phosphate-induced nociceptor excitation and ongoing pain behavior in mice and humans is largely mediated by S1P3 receptor. 2013 J. Neurosci. pmid:23392686
Pantoja M et al. Genetic elevation of sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila. 2013 Development pmid:23154413
Takahashi K et al. Novel therapy for liver regeneration by increasing the number of platelets. 2013 Surg. Today pmid:23180116
Lidington D et al. Capitalizing on diversity: an integrative approach towards the multiplicity of cellular mechanisms underlying myogenic responsiveness. 2013 Cardiovasc. Res. pmid:23180720
Nagahashi M et al. Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network. 2013 FASEB J. pmid:23180825
Huang J et al. Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway. 2013 Mol. Cell. Endocrinol. pmid:23127801
Cartwright TA et al. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers. 2013 J. Cereb. Blood Flow Metab. pmid:23168528
Véret J et al. Role of palmitate-induced sphingoid base-1-phosphate biosynthesis in INS-1 β-cell survival. 2013 Biochim. Biophys. Acta pmid:23085009
Bruni P and Donati C Role of sphingosine 1-phosphate in skeletal muscle cell biology. 2013 Handb Exp Pharmacol pmid:23563671
Vessey DA et al. FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning. 2013 Med Sci Monit Basic Res pmid:23567658
Wallington-Beddoe CT et al. Oncogenic properties of sphingosine kinases in haematological malignancies. 2013 Br. J. Haematol. pmid:23521541
Bendall LJ and Basnett J Role of sphingosine 1-phosphate in trafficking and mobilization of hematopoietic stem cells. 2013 Curr. Opin. Hematol. pmid:23507960
Erkhembaatar LO et al. Increased expression of sphingosine kinase in the amnion during labor. 2013 Placenta pmid:23462226
Kikuta J et al. Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23569273
Nguyen DH et al. Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23569284
Alberg AJ et al. Plasma sphingolipids and lung cancer: a population-based, nested case-control study. 2013 Cancer Epidemiol. Biomarkers Prev. pmid:23749868
Willis MA and Cohen JA Fingolimod therapy for multiple sclerosis. 2013 Semin Neurol pmid:23709211
Tatematsu S et al. Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium. 2013 Arterioscler. Thromb. Vasc. Biol. pmid:23723371
Guo L et al. Sphingosine-1-phosphate inhibits ceramide-induced apoptosis during murine preimplantation embryonic development. 2013 Theriogenology pmid:23731666
Pyne NJ et al. Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis. 2013 Biochim. Biophys. Acta pmid:22801038
Zhang L et al. Sphingosine kinase 2 (Sphk2) regulates platelet biogenesis by providing intracellular sphingosine 1-phosphate (S1P). 2013 Blood pmid:23775711
Koch A et al. Sphingosine 1-phosphate in renal diseases. 2013 Cell. Physiol. Biochem. pmid:23736205
Ohkuni A et al. Identification of acyl-CoA synthetases involved in the mammalian sphingosine 1-phosphate metabolic pathway. 2013 Biochem. Biophys. Res. Commun. pmid:24269233
Ito S et al. Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes. 2013 Coron. Artery Dis. pmid:24212262
Lim SH et al. Complementary effects of ciclopirox olamine, a prolyl hydroxylase inhibitor and sphingosine 1-phosphate on fibroblasts and endothelial cells in driving capillary sprouting. 2013 Integr Biol (Camb) pmid:24190477
Lamichhane A et al. Nutritional components regulate the gut immune system and its association with intestinal immune disease development. 2013 J. Gastroenterol. Hepatol. pmid:24251698